Bigul

TORRENT PHARMACEUTICALS LTD. - 500420 - Clarification / Information On News Item

Clarification / information on news item
01-09-2023
Bigul

TORRENT PHARMACEUTICALS LTD. - 500420 - Clarification sought from Torrent Pharmaceuticals Ltd

The Exchange has sought clarification from Torrent Pharmaceuticals Ltd on August 31, 2023, with reference to news appeared in ET NOW dated August 31, 2023 quoting"Torrent Pharma is in talks to acquire Cipla Ltd."The reply is awaited.
31-08-2023
Bigul

TORRENT PHARMACEUTICALS LTD. - 500420 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

Torrent Pharmaceuticals gets EIR from US FDA for Dahej facility
24-08-2023

Torrent Pharmaceutical gains on USFDA relief for Dahej plant

The FDA's 'voluntary action indicated classification' means that Torrent Pharma will be now able to get approval for all pending Abbreviated New Drug Applications from the site
24-08-2023
Bigul

TORRENT PHARMACEUTICALS LTD. - 500420 - Intimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015

Intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
24-08-2023
Bigul

TORRENT PHARMACEUTICALS LTD. - 500420 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript

Transcript of Conference call with Analysts / investors on financial results for the quarter ended 30th June, 2023 attached.
11-08-2023

Buy Torrent Pharmaceuticals; target of Rs 2250: Prabhudas Lilladher

Prabhudas Lilladher is bullish on Torrent Pharmaceuticals has recommended buy rating on the stock with a target price of Rs 2250 in its research report dated August 08, 2023.
10-08-2023
Next Page
Close

Let's Open Free Demat Account